Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Frazier Lifesciences Acquisition Equity-to-Asset Related Terms
Frazier Lifesciences Acquisition Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FLACW vs OMEG, LJAQ, GSQB: Equity-to-Asset Comparison
For the Shell Companies subindustry, Frazier Lifesciences Acquisition's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frazier Lifesciences Acquisition Equity-to-Asset vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Frazier Lifesciences Acquisition's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Frazier Lifesciences Acquisition's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frazier Lifesciences Acquisition (FLACW) has a Equity-to-Asset of 0.91 as of Sep. 2022. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Frazier Lifesciences Acquisition and its competitors. This is near median its historical median of 0.93. Over the past decade, Frazier Lifesciences Acquisition's Equity-to-Asset has ranged from 0.44 to 0.96.
Is Frazier Lifesciences Acquisition's Equity-to-Asset too high?
Frazier Lifesciences Acquisition's current Equity-to-Asset of 0.91 is near median its 10-year median of 0.93. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 0.96. The Diversified Financial Services industry median Equity-to-Asset is 0.91. Frazier Lifesciences Acquisition's value of 0.91 is 0% at this industry median. Overall, Frazier Lifesciences Acquisition has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Frazier Lifesciences Acquisition's Equity-to-Asset compare to OMEG and LJAQ?
Frazier Lifesciences Acquisition's Equity-to-Asset of 0.91 can be compared against companies in the Diversified Financial Services industry. The industry median Equity-to-Asset is 0.91. Frazier Lifesciences Acquisition's value of 0.91 is 0% at this benchmark. Historically, Frazier Lifesciences Acquisition's own Equity-to-Asset has ranged from 0.44 to 0.96 over the past decade. While the company's 10-year median is 0.93 vs. the industry median of 0.91, Frazier Lifesciences Acquisition has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Diversified Financial Services company?
The median Equity-to-Asset among Diversified Financial Services companies is 0.91, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frazier Lifesciences Acquisition's current Equity-to-Asset of 0.91 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Frazier Lifesciences Acquisition and its competitors. For the Diversified Financial Services industry, the median Equity-to-Asset is 0.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frazier Lifesciences Acquisition's current Equity-to-Asset is 0.91, which is near median its own 10-year median of 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frazier Lifesciences Acquisition stock overvalued right now?
Frazier Lifesciences Acquisition (FLACW) has a current Equity-to-Asset of 0.91. The current Equity-to-Asset is 0.91, which is near median its 10-year median of 0.93 and 0% at the Diversified Financial Services industry median of 0.91. Frazier Lifesciences Acquisition's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Frazier Lifesciences Acquisition (FLACW), the current Equity-to-Asset is 0.91 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FLACW has been successfully added to your 
